| Name | Title | Contact Details |
|---|
At Neopenda, we believe that the most vulnerable patient populations in the world deserve access to high quality health care. We re a social enterprise startup passionate about improving newborn health through innovative technology solutions, and implementing them sustainably in emerging markets. Neopendas first product is a scalable wireless vital signs monitor for patients in overcrowded, understaffed health facilities. Our solution reduces response time to newborns in distress, and helps healthcare workers to save more lives. We are currently validating our technology in clinical studies with our partners in Uganda.
Vapotherm, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.
GD USA is a Beaverton, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Argen is the largest dental gold producer in the world and the USA. Argen started as a small business with a focus on complete customer satisfaction. Although the business has grown significantly over the years, our personal touch and customer service are unmatched in the marketplace, and we pride ourselves on being the benchmark for unsurpassed quality.
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.